Category Archives: Z Medical centers

Review of immunotherapy and targeted therapy

June 17, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma, to go over the

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The Miami Summit on Healthcare Spending Reduction

June 29, 2010 Produced and interviewed by Steven Greer, MD The Healthcare Channel and The University of Miami Health System hosted a roundtable discussion

Posted in - Policy, CMS, Congress, Univ Miami | Leave a comment

Apple, Google, and Amazon need to make their own hospitals

Update February 27, 2018- Well, they used my idea from two-years ago. Amazon, Warren Buffet,

Posted in - Medical Devices, - Opinion, CMS, Congress, Z Medical centers | Leave a comment

Ocrelizumab (Ocrevus) versus Placebo in Primary Progressive Multiple Sclerosis

January 31, 2017- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Pharma, Neurology, Univ Texas | 1 Comment

CT-scan screening for heart disease fails to show benefit

March 23, 2015- Interviewed by Steven E. Greer, MD We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke.

Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

Maybe my brain was spared

July 26, 2017- by Steven E. Greer, MD Last week, I sat next to an Ohio State University offensive lineman while attending a Roger Waters

Posted in - JAMA, - Reviews, books, devices, Neurology, Neurosurgery, Ohio State | 1 Comment

Vagal nerve stimulation for weight loss

January 22, 2015- Interviewed by Steven E. Greer, MD Erik Dutson, MD, bariatric surgeon from UCLA, discusses the newly FDA-approved weight loss device called

Posted in - Medical Devices, Bariatric surgery, Diabetes and endocrinology, Gastroenterology and liver, Primary care medicine, UCLA | Leave a comment

Review of combination immunotherapies seen at ASCO 2016

June 22, 2016- interviewed by Steven E. Greer, MD We interviewed Siwen Hu-Lieskovan MD, PhD of UCLA, an expert with immunotherapies for melanoma,

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The 23andMe home genetics test kit controversy

December 19, 2013- Interviewed by Steven E. Greer,  MD

Posted in Columbia, FDA, Genetics, NIH, Oncology, Psychology Psychiatry | Leave a comment

The bionic pancreas data

July 2, 2014- Interviewed by Steven E. Greer, MD The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas”

Posted in - Medical Devices, - NEJM, Boston University, Diabetes and endocrinology | Leave a comment

Changes in plastic surgery training programs

March 3, 2015- Interviewed by Steven E. Greer, MD In Part 1 of our interview with the new Chairman of Plastic Surgery at NYU, Eduardo Rodriguez,

Posted in - Policy, NYU, Plastic surgery | Leave a comment

The Deans of Johns Hopkins and Miami discuss ACO’s

February 28, 2011- By Steven E Greer, MD Dean Miller of Johns Hopkins and Dean Goldschmidt of Miami discuss accountable care organizations,

Posted in - Policy, CMS, Johns Hopkins | Leave a comment

Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults

June 14, 2017- Interviewed by Steven E. Greer, MD We interviewed Dennis Villareal, MD, the author of the NEJM paper “Aerobic or Resistance

Posted in - NEJM, Bariatric surgery, Baylor, Diabetes and endocrinology, Geriatrics, Internal Medicine | Leave a comment

The egregious athletic coaching most kids receive

March 25, 2016- by Steven E. Greer, MD In 2005, at age 37, I got some good PGA golf lessons at Muirfield Golf Club in Ohio: Jack Nicklaus’

Posted in - Opinion, - Reviews, books, devices, Ohio State, Sports medicine | Leave a comment

Early stoppage of clinical trials

April 16, 2009– Dr. Guyatt explained in a previous post why early stoppage of clinical trials results

Posted in Cardiac surgery, FDA, McMaster University | Leave a comment

Insurance companies are not paying for Repatha and Praluent

March 8, 2017- Interviewed by Steven E. Greer, MD We interviewed cardiologist William O’Neill, MD about his personal need for the cholesterol-lowering, large-molecule, antibody drug from Amgen, branded as Repatha. Despite

Posted in - Biotech, - Pharma, - Policy, Cardiac surgery, Cardiology, Henry Ford, Primary care medicine | 1 Comment

New treatment paradigm for C. Diff colitis

March 31, 2010- Produced and interviewed by Steven E. Greer, MD New drugs

Posted in CDC, Gastroenterology and liver, General surgery, Infectious disease, Michigan, Primary care medicine | Leave a comment

CheckMate 026: Why did Opdivo (nivolumab) fail in NSCLC?

September 1, 2016- Interviewed by Steven E. Greer, MD In the wake of the news-making failure of CheckMate 026 of Bristol-Myers Squibb’s Opdivo (nivolumab) fail in

Posted in - Biotech, - Pharma, Oncology, UCLA | Leave a comment

The ACA’s THC program: A pilot program to fund residency training outside of the traditional hospital setting

September 6, 2016- Interviewed by Steven E. Greer, MD

Posted in - NEJM, - Policy, CMS, George Washington Univ | Leave a comment